Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial

NCT00602420 is registered in ClinicalTrials.gov with Gary Morrow as lead sponsor.

NCT NCT00602420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00602420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP): A Phase III Double-Blind Placebo-Controlled Clinical Trial
Lead sponsor
Gary Morrow
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2012
Enrollment
510 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

musculoskeletal complications, pain, unspecified adult solid tumor, protocol specific